OptimizeRx: Q4 Earnings Insights


OptimizeRx OPRX reported its Q4 earnings results on Thursday, February 24, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.


OptimizeRx beat estimated earnings by 10.0%, reporting an EPS of $0.22 versus an estimate of $0.2.

Revenue was up $3.89 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.04 which was followed by a 0.05% drop in the share price the next day.

Here's a look at OptimizeRx's past performance:


Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate 0.13 0.07 0.01 0.15
EPS Actual 0.09 0.10 0.03 0.16
Revenue Estimate 15.06M 12.45M 10.47M 16.02M
Revenue Actual 16.12M 13.63M 11.23M 16.43M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!